Company Overview

ViewRay® Inc., (NASDAQ:VRAY), designs, manufactures and markets MRIdian® the world’s first MRI-guided radiation therapy system that can image and treat cancer patients simultaneously. MRIdian addresses key limitations of existing external-beam radiation therapy technologies because it integrates MRI technology, radiation delivery, and proprietary software to locate, target, and track the position and shape of soft-tissue tumors while radiation is delivered. Real-time MRI-imaging clearly defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment allowing the system to deliver radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian’s targeting accuracy combined with improved tumor visibility and accurate dose recording means clinicians can treat patients who may not previously have been considered radiation therapy candidates. ViewRay believes MRIdian may improve the safety and efficacy of radiation therapy, potentially leading to improved patient outcomes with reduced side-effects from off-target radiation delivery.

Financial News

Date Title and Summary Additional Formats
Toggle Summary ViewRay Reports First Quarter 2021 Results
CLEVELAND , May 6, 2021 /PRNewswire/ --   ViewRay, Inc. (Nasdaq: VRAY) (the "Company") today announced financial results for the first quarter ended March 31, 2021 . First Quarter 2021 Highlights Received seven new orders for MRIdian systems totaling $40.9 million , compared to four new orders
Toggle Summary ViewRay Announces Conference Call for First Quarter 2021 Financial Results to be Held After Market on May 6, 2021
CLEVELAND , April 19, 2021 /PRNewswire/ --  ViewRay, Inc. (Nasdaq: VRAY) announced today details relating to the release of its first quarter 2021 financial results. ViewRay will hold a conference call to discuss results on Thursday, May 6, 2021 at 4:30 p.m. ET / 1:30 p.m. PT .
Toggle Summary ViewRay Announces Departure of Chief Operating Officer
CLEVELAND , March 15, 2021 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) ("the Company") today announced that Shahriar Matin , Chief Operating Officer, will leave the Company effective March 31, 2021 . Matin was named Chief Executive Officer designate of Cordis in its recently announced divestiture
Toggle Summary ViewRay To Participate in the 21st Annual Oppenheimer Healthcare Conference
CLEVELAND , March 5, 2021 /PRNewswire/ --  ViewRay, Inc. (NASDAQ: VRAY) (the "Company") today announced that members of management will be participating in the 21 st Annual Oppenheimer Healthcare Conference on Tuesday, March 16, 2021 .  ViewRay will be conducting a virtual fireside chat at 3:50 PM

Stock Quote

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Financial Events
More events are coming soon.

E-mail Alerts

Alerts are e-mailed to you whenever certain new company information is posted to this site. Sign-up Now!
Click here for E-mail Alerts

Transfer Agent
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
(800) 937-5449

In Need of Customer Support? Contact

  Language Select